<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Evox-Therapeutics on Bioecon</title><link>https://en.bioecon.ru/companies/evox-therapeutics/</link><description>Recent content in Evox-Therapeutics on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sat, 04 Jul 2026 20:58:24 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/evox-therapeutics/index.xml" rel="self" type="application/rss+xml"/><item><title>Exosome therapy &amp; extracellular vesicles</title><link>https://en.bioecon.ru/technology/exosome-therapy-extracellular-vesicles/</link><pubDate>Sat, 04 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/exosome-therapy-extracellular-vesicles/</guid><description>Cell-derived nanoscale vesicles (30-150 nm) used as native regenerative-medicine agents or engineered as biocompatible drug-delivery vehicles for RNA, protein and gene-editing cargo, crossing biological barriers artificial lipid nanoparticles cannot.</description></item></channel></rss>